AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2017
Nov 24, 2017
33510_dirs_2017-11-24_edd57587-f8be-492e-b963-e6e9fabc08be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-11-21
Reporting Person: Austin Mark John (Controller/Prin Fin&Acct Offic)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-21 | Common Stock | P | 2000 | $0.471 | Acquired | 2000 | Direct |
| 2017-11-21 | Common Stock | P | 3400 | $0.485 | Acquired | 5400 | Direct |
| 2017-11-22 | Common Stock | P | 1825 | $0.49 | Acquired | 7225 | Direct |
| 2017-11-24 | Common Stock | P | 500 | $0.4950 | Acquired | 7725 | Direct |
| 2017-11-24 | Common Stock | P | 515 | $0.4950 | Acquired | 8240 | Direct |
| 2017-11-24 | Common Stock | P | 1025 | $0.49 | Acquired | 9265 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16